How big is the long acting drug delivery market?

BUY CHAPTERS

Global Long Acting Drug Delivery Market Research Report 2022

Code: QYRE-Auto-36P10344

Report

March 2022

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ViiV Healthcare

Halozyme Therapeutics

Lubrizol Life Science

Celanese Corporation

Kashiv BioSciences

Ipsen S A

Midatech Pharma

Re-Vana Therapeutics

Creative-Biolabs

4P Therapeutics

Long Acting Drug Delivery Market Outlook - 2028

The global Long Acting Drug Delivery market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Device accounting for % of the Long Acting Drug Delivery global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028.

While Hospital segment is altered to an % CAGR throughout this forecast period.

Long Acting Drug Delivery Market Growth

Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.

China Long Acting Drug Delivery market size is valued at US$ million in 2021, while the North America and Europe Long Acting Drug Delivery are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Long Acting Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Long Acting Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Long Acting Drug Delivery market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Long Acting Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Long Acting Drug Delivery market.

Long Acting Drug Delivery Market Scope and Market Size

Long Acting Drug Delivery market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Long Acting Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment By Type

Device
Parenteral Injections

Segment By Application

Hospital
Specialty Clinics
Clinical Research Institutes
Others

By Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company

ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Long Acting Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Device

1.2.3 Parenteral Injections

1.3 Market by Application

1.3.1 Global Long Acting Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Specialty Clinics

1.3.4 Clinical Research Institutes

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Long Acting Drug Delivery Market Perspective (2017-2028)

2.2 Long Acting Drug Delivery Growth Trends by Region

2.2.1 Long Acting Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Long Acting Drug Delivery Historic Market Size by Region (2017-2022)

2.2.3 Long Acting Drug Delivery Forecasted Market Size by Region (2023-2028)

2.3 Long Acting Drug Delivery Market Dynamics

2.3.1 Long Acting Drug Delivery Industry Trends

2.3.2 Long Acting Drug Delivery Market Drivers

2.3.3 Long Acting Drug Delivery Market Challenges

2.3.4 Long Acting Drug Delivery Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Long Acting Drug Delivery Players by Revenue

3.1.1 Global Top Long Acting Drug Delivery Players by Revenue (2017-2022)

3.1.2 Global Long Acting Drug Delivery Revenue Market Share by Players (2017-2022)

3.2 Global Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Long Acting Drug Delivery Revenue

3.4 Global Long Acting Drug Delivery Market Concentration Ratio

3.4.1 Global Long Acting Drug Delivery Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Long Acting Drug Delivery Revenue in 2021

3.5 Long Acting Drug Delivery Key Players Head office and Area Served

3.6 Key Players Long Acting Drug Delivery Product Solution and Service

3.7 Date of Enter into Long Acting Drug Delivery Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Long Acting Drug Delivery Breakdown Data by Type

4.1 Global Long Acting Drug Delivery Historic Market Size by Type (2017-2022)

4.2 Global Long Acting Drug Delivery Forecasted Market Size by Type (2023-2028)

5 Long Acting Drug Delivery Breakdown Data by Application

5.1 Global Long Acting Drug Delivery Historic Market Size by Application (2017-2022)

5.2 Global Long Acting Drug Delivery Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Long Acting Drug Delivery Market Size (2017-2028)

6.2 North America Long Acting Drug Delivery Market Size by Country (2017-2022)

6.3 North America Long Acting Drug Delivery Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7 Europe

7.1 Europe Long Acting Drug Delivery Market Size (2017-2028)

7.2 Europe Long Acting Drug Delivery Market Size by Country (2017-2022)

7.3 Europe Long Acting Drug Delivery Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Long Acting Drug Delivery Market Size (2017-2028)

8.2 Asia-Pacific Long Acting Drug Delivery Market Size by Country (2017-2022)

8.3 Asia-Pacific Long Acting Drug Delivery Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9 Latin America

9.1 Latin America Long Acting Drug Delivery Market Size (2017-2028)

9.2 Latin America Long Acting Drug Delivery Market Size by Country (2017-2022)

9.3 Latin America Long Acting Drug Delivery Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Long Acting Drug Delivery Market Size (2017-2028)

10.2 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2017-2022)

10.3 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11 Key Players Profiles

11.1 ViiV Healthcare

11.1.1 ViiV Healthcare Company Detail

11.1.2 ViiV Healthcare Business Overview

11.1.3 ViiV Healthcare Long Acting Drug Delivery Introduction

11.1.4 ViiV Healthcare Revenue in Long Acting Drug Delivery Business (2017-2022)

11.1.5 ViiV Healthcare Recent Development

11.2 Halozyme Therapeutics

11.2.1 Halozyme Therapeutics Company Detail

11.2.2 Halozyme Therapeutics Business Overview

11.2.3 Halozyme Therapeutics Long Acting Drug Delivery Introduction

11.2.4 Halozyme Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)

11.2.5 Halozyme Therapeutics Recent Development

11.3 Lubrizol Life Science

11.3.1 Lubrizol Life Science Company Detail

11.3.2 Lubrizol Life Science Business Overview

11.3.3 Lubrizol Life Science Long Acting Drug Delivery Introduction

11.3.4 Lubrizol Life Science Revenue in Long Acting Drug Delivery Business (2017-2022)

11.3.5 Lubrizol Life Science Recent Development

11.4 Celanese Corporation

11.4.1 Celanese Corporation Company Detail

11.4.2 Celanese Corporation Business Overview

11.4.3 Celanese Corporation Long Acting Drug Delivery Introduction

11.4.4 Celanese Corporation Revenue in Long Acting Drug Delivery Business (2017-2022)

11.4.5 Celanese Corporation Recent Development

11.5 Kashiv BioSciences

11.5.1 Kashiv BioSciences Company Detail

11.5.2 Kashiv BioSciences Business Overview

11.5.3 Kashiv BioSciences Long Acting Drug Delivery Introduction

11.5.4 Kashiv BioSciences Revenue in Long Acting Drug Delivery Business (2017-2022)

11.5.5 Kashiv BioSciences Recent Development

11.6 4P Therapeutics

11.6.1 4P Therapeutics Company Detail

11.6.2 4P Therapeutics Business Overview

11.6.3 4P Therapeutics Long Acting Drug Delivery Introduction

11.6.4 4P Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)

11.6.5 4P Therapeutics Recent Development

11.7 Ipsen

11.7.1 Ipsen Company Detail

11.7.2 Ipsen Business Overview

11.7.3 Ipsen Long Acting Drug Delivery Introduction

11.7.4 Ipsen Revenue in Long Acting Drug Delivery Business (2017-2022)

11.7.5 Ipsen Recent Development

11.8 Midatech Pharma

11.8.1 Midatech Pharma Company Detail

11.8.2 Midatech Pharma Business Overview

11.8.3 Midatech Pharma Long Acting Drug Delivery Introduction

11.8.4 Midatech Pharma Revenue in Long Acting Drug Delivery Business (2017-2022)

11.8.5 Midatech Pharma Recent Development

11.9 Re-Vana Therapeutics

11.9.1 Re-Vana Therapeutics Company Detail

11.9.2 Re-Vana Therapeutics Business Overview

11.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Introduction

11.9.4 Re-Vana Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)

11.9.5 Re-Vana Therapeutics Recent Development

11.10 Creative Biolabs

11.10.1 Creative Biolabs Company Detail

11.10.2 Creative Biolabs Business Overview

11.10.3 Creative Biolabs Long Acting Drug Delivery Introduction

11.10.4 Creative Biolabs Revenue in Long Acting Drug Delivery Business (2017-2022)

11.10.5 Creative Biolabs Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

ViiV Healthcare

Halozyme Therapeutics

Lubrizol Life Science

Celanese Corporation

Kashiv BioSciences

Ipsen S A

Midatech Pharma

Re-Vana Therapeutics

Creative-Biolabs

4P Therapeutics

List of Tables

Table 1. Global Long Acting Drug Delivery Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

Table 2. Key Players of Device

Table 3. Key Players of Parenteral Injections

Table 4. Global Long Acting Drug Delivery Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

Table 5. Global Long Acting Drug Delivery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global Long Acting Drug Delivery Market Size by Region (2017-2022) & (US$ Million)

Table 7. Global Long Acting Drug Delivery Market Share by Region (2017-2022)

Table 8. Global Long Acting Drug Delivery Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 9. Global Long Acting Drug Delivery Market Share by Region (2023-2028)

Table 10. Long Acting Drug Delivery Market Trends

Table 11. Long Acting Drug Delivery Market Drivers

Table 12. Long Acting Drug Delivery Market Challenges

Table 13. Long Acting Drug Delivery Market Restraints

Table 14. Global Long Acting Drug Delivery Revenue by Players (2017-2022) & (US$ Million)

Table 15. Global Long Acting Drug Delivery Market Share by Players (2017-2022)

Table 16. Global Top Long Acting Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Drug Delivery as of 2021)

Table 17. Ranking of Global Top Long Acting Drug Delivery Companies by Revenue (US$ Million) in 2021

Table 18. Global 5 Largest Players Market Share by Long Acting Drug Delivery Revenue (CR5 and HHI) & (2017-2022)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Long Acting Drug Delivery Product Solution and Service

Table 21. Date of Enter into Long Acting Drug Delivery Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Long Acting Drug Delivery Market Size by Type (2017-2022) & (US$ Million)

Table 24. Global Long Acting Drug Delivery Revenue Market Share by Type (2017-2022)

Table 25. Global Long Acting Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 26. Global Long Acting Drug Delivery Revenue Market Share by Type (2023-2028)

Table 27. Global Long Acting Drug Delivery Market Size by Application (2017-2022) & (US$ Million)

Table 28. Global Long Acting Drug Delivery Revenue Market Share by Application (2017-2022)

Table 29. Global Long Acting Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 30. Global Long Acting Drug Delivery Revenue Market Share by Application (2023-2028)

Table 31. North America Long Acting Drug Delivery Market Size by Country (2017-2022) & (US$ Million)

Table 32. North America Long Acting Drug Delivery Market Size by Country (2023-2028) & (US$ Million)

Table 33. Europe Long Acting Drug Delivery Market Size by Country (2017-2022) & (US$ Million)

Table 34. Europe Long Acting Drug Delivery Market Size by Country (2023-2028) & (US$ Million)

Table 35. Asia-Pacific Long Acting Drug Delivery Market Size by Region (2017-2022) & (US$ Million)

Table 36. Asia-Pacific Long Acting Drug Delivery Market Size by Region (2023-2028) & (US$ Million)

Table 37. Latin America Long Acting Drug Delivery Market Size by Country (2017-2022) & (US$ Million)

Table 38. Latin America Long Acting Drug Delivery Market Size by Country (2023-2028) & (US$ Million)

Table 39. Middle East & Africa Long Acting Drug Delivery Market Size by Country (2017-2022) & (US$ Million)

Table 40. Middle East & Africa Long Acting Drug Delivery Market Size by Country (2023-2028) & (US$ Million)

Table 41. ViiV Healthcare Company Detail

Table 42. ViiV Healthcare Business Overview

Table 43. ViiV Healthcare Long Acting Drug Delivery Product

Table 44. ViiV Healthcare Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)

Table 45. ViiV Healthcare Recent Development

Table 46. Halozyme Therapeutics Company Detail

Table 47. Halozyme Therapeutics Business Overview

Table 48. Halozyme Therapeutics Long Acting Drug Delivery Product

Table 49. Halozyme Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)

Table 50. Halozyme Therapeutics Recent Development

Table 51. Lubrizol Life Science Company Detail

Table 52. Lubrizol Life Science Business Overview

Table 53. Lubrizol Life Science Long Acting Drug Delivery Product

Table 54. Lubrizol Life Science Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)

Table 55. Lubrizol Life Science Recent Development

Table 56. Celanese Corporation Company Detail

Table 57. Celanese Corporation Business Overview

Table 58. Celanese Corporation Long Acting Drug Delivery Product

Table 59. Celanese Corporation Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)

Table 60. Celanese Corporation Recent Development

Table 61. Kashiv BioSciences Company Detail

Table 62. Kashiv BioSciences Business Overview

Table 63. Kashiv BioSciences Long Acting Drug Delivery Product

Table 64. Kashiv BioSciences Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)

Table 65. Kashiv BioSciences Recent Development

Table 66. 4P Therapeutics Company Detail

Table 67. 4P Therapeutics Business Overview

Table 68. 4P Therapeutics Long Acting Drug Delivery Product

Table 69. 4P Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)

Table 70. 4P Therapeutics Recent Development

Table 71. Ipsen Company Detail

Table 72. Ipsen Business Overview

Table 73. Ipsen Long Acting Drug Delivery Product

Table 74. Ipsen Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)

Table 75. Ipsen Recent Development

Table 76. Midatech Pharma Company Detail

Table 77. Midatech Pharma Business Overview

Table 78. Midatech Pharma Long Acting Drug Delivery Product

Table 79. Midatech Pharma Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)

Table 80. Midatech Pharma Recent Development

Table 81. Re-Vana Therapeutics Company Detail

Table 82. Re-Vana Therapeutics Business Overview

Table 83. Re-Vana Therapeutics Long Acting Drug Delivery Product

Table 84. Re-Vana Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)

Table 85. Re-Vana Therapeutics Recent Development

Table 86. Creative Biolabs Company Detail

Table 87. Creative Biolabs Business Overview

Table 88. Creative Biolabs Long Acting Drug Delivery Product

Table 89. Creative Biolabs Revenue in Long Acting Drug Delivery Business (2017-2022) & (US$ Million)

Table 90. Creative Biolabs Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Long Acting Drug Delivery Market Share by Type: 2021 VS 2028

Figure 2. Device Features

Figure 3. Parenteral Injections Features

Figure 4. Global Long Acting Drug Delivery Market Share by Application in 2021 & 2028

Figure 5. Hospital Case Studies

Figure 6. Specialty Clinics Case Studies

Figure 7. Clinical Research Institutes Case Studies

Figure 8. Others Case Studies

Figure 9. Long Acting Drug Delivery Report Years Considered

Figure 10. Global Long Acting Drug Delivery Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 11. Global Long Acting Drug Delivery Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Long Acting Drug Delivery Market Share by Region: 2021 VS 2028

Figure 13. Global Long Acting Drug Delivery Market Share by Players in 2021

Figure 14. Global Top Long Acting Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Drug Delivery as of 2021)

Figure 15. The Top 10 and 5 Players Market Share by Long Acting Drug Delivery Revenue in 2021

Figure 16. North America Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 17. North America Long Acting Drug Delivery Market Share by Country (2017-2028)

Figure 18. United States Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 19. Canada Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 20. Europe Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Europe Long Acting Drug Delivery Market Share by Country (2017-2028)

Figure 22. Germany Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. France Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 24. U.K. Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 25. Italy Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 26. Russia Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. Nordic Countries Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. Asia-Pacific Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Asia-Pacific Long Acting Drug Delivery Market Share by Region (2017-2028)

Figure 30. China Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Japan Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. South Korea Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Southeast Asia Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. India Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 35. Australia Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 36. Latin America Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. Latin America Long Acting Drug Delivery Market Share by Country (2017-2028)

Figure 38. Mexico Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Brazil Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Middle East & Africa Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. Middle East & Africa Long Acting Drug Delivery Market Share by Country (2017-2028)

Figure 42. Turkey Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. Saudi Arabia Long Acting Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 44. ViiV Healthcare Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)

Figure 45. Halozyme Therapeutics Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)

Figure 46. Lubrizol Life Science Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)

Figure 47. Celanese Corporation Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)

Figure 48. Kashiv BioSciences Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)

Figure 49. 4P Therapeutics Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)

Figure 50. Ipsen Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)

Figure 51. Midatech Pharma Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)

Figure 52. Re-Vana Therapeutics Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)

Figure 53. Creative Biolabs Revenue Growth Rate in Long Acting Drug Delivery Business (2017-2022)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Long Acting Drug Delivery Market Research Report 2022

Published Date: March 2022

Report Code: QYRE-Auto-36P10344

Global Long Acting Drug Delivery Market Research Report 2022

FEATURED COMPANIES

Long Acting Drug Delivery Market Outlook - 2028

Long Acting Drug Delivery Market Growth

Long Acting Drug Delivery Market Scope and Market Size

Segment By Type

Segment By Application

By Region

By Company

FEATURED COMPANIES